2/12/25 17:04 | 2/11/25 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Erickson Michael G | ME | O | EVP | 1 | M.d | 105 | 67.85 | 0 | 2 | 8 | 21 | D | | | | | | | | | | | | | | |
2/11/25 19:00 | 2/7/25 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | James Andrea S. | CA | O | CFO | 2 | P | 246 | 2.09 | 0 | 118 | 349 | 151 | D | | | | | | | | | | | | | | |
2/11/25 17:00 | 2/7/25 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Smith Patrick W | CA | T | | 5 | P.m | 2,446 | 2.06 | 0 | 1,189 | 57 | 3,258 | I | | | | | | | | | | | | | | |
2/11/25 17:00 | 2/7/25 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Fennell George | ME | O | EVP | 2 | M.dm | 5,513 | 259.71 | 0 | 21 | | 8 | D | | | | | | | | | | | | | | |
2/11/25 17:00 | 2/10/25 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Fennell George | ME | O | EVP | 2 | S.dm | -5,513 | 259.71 | 0 | -21 | | 8 | D | | | | | | | | | | | | | | |
2/10/25 20:43 | 2/6/25 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Broadwood Partners, L.P. | NY | T | | 1 | P.d | 10,590 | 2.05 | 0 | 5,166 | 29 | 22,820 | M | | | | | | | | | | | | | | |
2/3/25 19:26 | 1/31/25 | IONS | Ionis Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hougen Elizabeth L | CA | O | EVP,Fina | 3 | S.d | -340 | 9.93 | 0 | -34 | | 111 | D | | | | | | | | | | | | | | |
1/31/25 16:17 | 1/29/25 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bhanji Muna | MA | D | | 1 | S | -3 | 9.97 | 0 | 0 | | 19 | D | | | | | | | | | | | | | | |
1/29/25 17:20 | 12/31/24 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Milligan Sandra | TX | O | Interim | 2 | M.d | 0 | 0.00 | 0 | 40 | | 20 | D | | | | | | | | | | | | | | |
1/17/25 16:15 | 1/15/25 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Thrall James H | MA | D | | 1 | S | -95 | 94.76 | 0 | -1 | | 33 | D | | | | | | | | | | | | | | |
1/16/25 15:28 | 1/16/25 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Naemura David H. | MI | O | CFO | 2 | P.d | 347 | 12.52 | 0 | 28 | 82 | 61 | D | | | | | | | | | | | | | | |
1/16/25 12:05 | 1/16/25 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | MI | O | CEO | 1 | P | 254 | 11.03 | 0 | 23 | 9 | 269 | D | | | | | | | | | | | | | | |
1/8/25 19:20 | 12/31/24 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Herchuk Jannie Prestridge | TX | D | | 1 | M.d | 0 | 0.00 | 0 | 8 | 15 | 66 | D | | | | | | | | | | | | | | |
1/8/25 19:12 | 12/31/24 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Fralick Celeste Rachelle | TX | D | | 1 | M.d | 0 | 0.00 | 0 | 5 | 11 | 51 | D | | | | | | | | | | | | | | |
1/8/25 19:05 | 12/31/24 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Parnell Winfred | TX | D | | 1 | M.d | 0 | 0.00 | 0 | 5 | 9 | 61 | D | | | | | | | | | | | | | | |
1/8/25 18:58 | 12/31/24 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cavanaugh Stefanie L. | TX | D | | 1 | M.d | 0 | 0.00 | 0 | 6 | 10 | 67 | D | | | | | | | | | | | | | | |
1/8/25 18:47 | 12/31/24 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ragard John Phillip | TX | D | | 2 | M.ad | 0 | 0.00 | 0 | 10 | 8 | 125 | D | | | | | | | | | | | | | | |
1/8/25 18:17 | 12/31/24 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Vos Ellen O'Connor | TX | D | | 1 | M.d | 0 | 0.00 | 0 | 5 | 9 | 63 | D | | | | | | | | | | | | | | |
1/7/25 17:23 | 1/3/25 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Dube Michael P | MA | O | VP,Chief | 1 | S | -17 | 12.18 | 0 | -1 | | 46 | D | | | | | | | | | | | | | | |
1/7/25 17:22 | 1/3/25 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Basta James | MA | O | EVP,GC | 1 | S | -86 | 12.18 | 0 | -7 | | 74 | D | | | | | | | | | | | | | | |
1/7/25 17:20 | 1/3/25 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lebwohl David | MA | O | EVP,Chie | 1 | S | -116 | 12.18 | 0 | -10 | | 88 | D | | | | | | | | | | | | | | |
1/7/25 17:20 | 1/3/25 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hicks Derek | MA | O | EVP,Chie | 1 | S | -79 | 12.18 | 0 | -7 | | 60 | D | | | | | | | | | | | | | | |
1/7/25 17:19 | 1/3/25 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | 1 | S | -327 | 12.18 | 0 | -27 | | 1,000 | D | | | | | | | | | | | | | | |
1/7/25 17:16 | 1/3/25 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sepp-Lorenzino Laura | MA | O | EVP,Chie | 1 | S | -109 | 12.18 | 0 | -9 | | 77 | D | | | | | | | | | | | | | | |
1/6/25 16:16 | 1/2/25 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Clark Eliana | MA | O | EVP,Chie | 1 | S.m | -97 | 12.17 | 0 | -8 | | 64 | D | | | | | | | | | | | | | | |
12/26/24 18:17 | 12/26/24 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Arno Andrew | CA | D | | 1 | P | 26 | 2.11 | 0 | 13 | 15 | 97 | D | | | | | | | | | | | | | | |
12/23/24 19:33 | 12/19/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Markison Brian A | MA | DO | CEO | 1 | M.d | 300 | 9.15 | 0 | 33 | 24 | 170 | D | | | | | | | | | | | | | | |
12/13/24 16:12 | 12/11/24 | QDEL | Quidelortho Corp | | Health | Diagn | In Vitro & In Vivo Diagnostic | Blaser Brian J. | CA | O | P,CEO | 1 | P | 250 | 41.42 | 0 | 6 | | 6 | I | | | | | | | | | | | | | | |
12/10/24 16:01 | 12/9/24 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | NV | D | | 1 | P | 100 | 0.5722 | 0 | 175 | 6 | 2,991 | D | | | | | | | | | | | | | | |
12/10/24 16:01 | 12/9/24 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Still Timothy I | NV | D | | 1 | P | 50 | 0.5722 | 0 | 87 | 6 | 1,487 | D | | | | | | | | | | | | | | |
12/10/24 16:01 | 12/9/24 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Micallef Jacob Vincent | NV | O | Chief Sc | 1 | P | 25 | 0.5722 | 0 | 44 | 10 | 487 | D | | | | | | | | | | | | | | |
12/10/24 16:01 | 12/9/24 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Reynolds Cameron John | NV | DO | P,CEO | 1 | P | 80 | 0.5722 | 0 | 140 | 5 | 3,159 | D | | | | | | | | | | | | | | |
11/29/24 17:00 | 11/27/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Vandebroek Sophie V. | ME | D | | 1 | S | -145 | 420.44 | 0 | 0 | | 1 | D | | | | | | | | | | | | | | |
11/21/24 18:30 | 11/19/24 | ORKA | Oruka Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Fairmount Funds Management LLC | PA | DT | | 1 | M.d | 0 | 0.00 | 0 | 160 | 5 | 3,372 | I | | | | | | | | | | | | | | |